| Lastest Insider Transactions Of ARROWHEAD PHARMACEUTICALS, INC. ( ARWR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | 2024-04-01 | Sell | 6,000 | 28.03 | 168,180 | 2024-04-03 18:05:30 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Directior | 2024-03-18 | Buy | 3,000 | 27.66 | 82,990 | 2024-03-20 19:06:58 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2024-03-06 | Sell | 40,000 | 35.19 | 1,407,600 | 2024-03-08 17:54:54 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-01-31 | Sell | 57,499 | 32.35 | 1,860,019 | 2024-02-02 17:25:50 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-01-31 | Option Exercise | 57,499 | 14.54 | 836,035 | 2024-02-02 17:25:50 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | 2024-01-12 | Sell | 7,940 | 36.89 | 292,904 | 2024-01-17 18:32:24 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2024-01-11 | Sell | 2,911 | 38.06 | 110,788 | 2024-01-16 18:06:55 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2024-01-11 | Sell | 3,934 | 38.07 | 149,759 | 2024-01-16 18:06:38 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Directior | 2024-01-11 | Sell | 3,147 | 38.06 | 119,787 | 2024-01-16 18:06:27 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Directior | 2024-01-11 | Sell | 4,720 | 38.10 | 179,813 | 2024-01-16 18:06:15 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Officer | 2024-01-04 | Sell | 74 | 33.89 | 2,508 | 2024-01-08 17:17:32 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2024-01-04 | Sell | 16,104 | 35.27 | 567,910 | 2024-01-08 17:16:49 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | 2024-01-04 | Sell | 8,303 | 35.26 | 292,804 | 2024-01-08 17:16:14 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2024-01-03 | Sell | 38,443 | 34.69 | 1,333,529 | 2024-01-05 20:02:55 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | 2024-01-03 | Sell | 33,190 | 34.36 | 1,140,362 | 2024-01-05 19:58:47 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-01-02 | Sell | 9,952 | 31.01 | 308,637 | 2024-01-04 17:25:05 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-12-20 | Sell | 12,000 | 28.54 | 342,480 | 2023-12-22 17:04:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | 2023-11-20 | Sell | 19,700 | 28.80 | 567,315 | 2023-11-22 14:31:42 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-10-25 | Sell | 24,338 | 24.21 | 589,223 | 2023-10-27 18:23:41 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Directior | 2023-09-28 | Sell | 1,550 | 26.33 | 40,812 | 2023-10-02 17:51:40 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-09-18 | Sell | 57,755 | 28.12 | 1,624,223 | 2023-09-20 18:10:16 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-09-18 | Option Exercise | 57,755 | 4.75 | 274,336 | 2023-09-20 18:10:16 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Officer | 2023-07-03 | Sell | 8,925 | 35.31 | 315,142 | 2023-07-06 18:04:30 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2023-06-30 | Sell | 3,000 | 35.53 | 106,590 | 2023-07-05 18:15:14 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2023-06-27 | Sell | 15,000 | 36.20 | 543,000 | 2023-06-29 18:41:22 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2023-05-05 | Sell | 6,500 | 40.90 | 265,850 | 2023-05-08 18:29:07 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-05-03 | Sell | 104,928 | 39.32 | 4,125,674 | 2023-05-05 19:04:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-05-03 | Option Exercise | 104,928 | 2.01 | 210,905 | 2023-05-05 19:04:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Directior | 2023-03-03 | Sell | 11,350 | 32.65 | 370,578 | 2023-03-06 18:04:30 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2023-02-27 | Sell | 875 | 32.62 | 28,543 | 2023-03-01 18:14:49 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2023-01-09 | Sell | 3,200 | 30.00 | 96,000 | 2023-01-11 20:23:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | 2023-01-05 | Sell | 15,000 | 37.39 | 560,850 | 2023-01-06 19:30:12 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2023-01-05 | Sell | 13,803 | 37.40 | 516,232 | 2023-01-06 19:24:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | 2023-01-03 | Sell | 17,500 | 38.33 | 670,802 | 2023-01-05 19:10:57 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2023-01-03 | Sell | 10,338 | 38.38 | 396,738 | 2023-01-05 19:05:58 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2022-12-29 | Sell | 30,625 | 40.00 | 1,225,000 | 2022-12-30 17:12:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | 2022-12-21 | Option Exercise | 32,000 | 6.15 | 196,800 | 2022-12-22 20:01:04 |
